Treace Medical Concepts, Inc.TT

Treace Medical Concepts, Inc.

5.85USDR
−0.01−0.17%
As of today at 16:17 GMT
USD
No trades
See on Supercharts

TMCI fundamentals

Key facts

Market capitalization‪367.99 M‬USD
Basic EPS (TTM)−0.85USD
Founded2013
CEOJohn T. Treace
Websitetreace.com
About

Treace Medical Concepts, Inc. engages in the design, manufacture, and marketing of orthopedic medical devices and biologic solutions. It offers Lapiplasty, a bunion surgery for three-dimensional bunion correction. It operates and distributes its products and services under the following trademarks: Treace Medical Concepts, Lapiplasty, Fast Grafter, Align My Toe, The Future of Hallux Valgus, Fix It Right The First Time, and Plantar Python. The company was founded by John T. Treace in July 2013 and is headquartered in Ponte Vedra Beach, FL.

Ownership
‪‪62.91 M‬‬
Free Float shares
‪‪44.63 M‬‬ (70.94%)
Closely held shares
‪‪18.28 M‬‬ (29.06%)
Free Float shares
‪‪44.63 M‬‬ (70.94%)
Closely held shares
‪‪18.28 M‬‬ (29.06%)
Capital structure
Market cap
‪‪367.99 M‬‬
Debt
‪‪69.36 M‬‬
Cash & equivalents
‪‪76.09 M‬‬
Enterprise value
‪‪361.27 M‬‬

Valuation

Fundamental metrics to determine fair value of the stock

Summary
‪‪367.99 M‬‬
Price to earning ratio (P/E)
Price to sales ratio (P/S)
1.74x
Market Cap
Net income
Revenue
Price to earning ratio (P/E)
Price to sales ratio (P/S)
1.74x
Valuation ratios
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪0.00‬
‪1.10‬
‪2.20‬
‪3.30‬
‪4.40‬
P/S

Growth and Profitability

Company’s recent performance and margins

Performance
‪−48.7%‬
‪−36.7%‬
‪−24.7%‬
‪−12.7%‬
‪−0.7%‬
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−25.00 M‬‬
‪0.00‬
‪‪25.00 M‬‬
‪‪50.00 M‬‬
‪‪75.00 M‬‬
Revenue
Net income
Net margin %
Revenue to profit conversion
Revenue
COGS
Gross profit
Op expenses
Op income
Non-Op income/ expenses
Taxes & Other
Net income
‪‪−20.00 M‬‬
‪0.00‬
‪‪20.00 M‬‬
‪‪40.00 M‬‬
‪‪60.00 M‬‬
Revenue
COGS
Gross profit
Expenses & adjustments
Net income
‪‪−20.00 M‬‬
‪0.00‬
‪‪20.00 M‬‬
‪‪40.00 M‬‬
‪‪60.00 M‬‬

Revenue breakdown

Revenue streams and regions a business earns money from

By source/business
Period: 2024
Medical Devices
By country
Period: 2024
United States

Estimates

Revenue and Earnings forecasts and estimates accuracy

Revenue
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪0.00‬
‪‪20.00 M‬‬
‪‪40.00 M‬‬
‪‪60.00 M‬‬
‪‪80.00 M‬‬
Actual
Estimate
Earnings
Next:Aug 12, 2025
Q2 '24
Q3 '24
Q4 '24
Q1 '25
Q2 '25
‪−0.36‬
‪−0.27‬
‪−0.18‬
‪−0.09‬
‪0.00‬
Actual
Estimate

Dividends

Dividend yield, history and sustainability

No dividends
TMCI has never paid dividends and has no current plans to do so.

Financial health

Financial position and solvency of the company

Debt level and coverage
Q1 '24
Q2 '24
Q3 '24
Q4 '24
Q1 '25
‪‪−25.00 M‬‬
‪0.00‬
‪‪25.00 M‬‬
‪‪50.00 M‬‬
‪‪75.00 M‬‬
Debt
Free cash flow
Cash & equivalents
Financial position analysis
Short term
Long term
‪0.00‬
‪‪40.00 M‬‬
‪‪80.00 M‬‬
‪‪120.00 M‬‬
‪‪160.00 M‬‬
Assets
Liabilities